Arbutus Biopharma Corp (ABUS) Peer Comparison
$5.13
As on 28-Aug-2026 13:40EDT
Market cap
$1,031 Mln
Revenue (TTM)
$182 Mln
P/E Ratio
6.1
P/B Ratio
3.6
Div. Yield
0 %
| Arbutus Biopharma Corp (ABUS) | Bausch Health Companies (BHC) | Cronos Group Inc. Common Share (CRON) | Sundial Growers - ADR | Canopy Growth Corp (CGC) | |
|---|---|---|---|---|---|
Market cap ($ Mln) |
1,031 | 2,409 | 1,219 | 341 | 499 |
Revenue ($ Mln) |
182 | 10,853 | 243 | 928 | 321 |
Net Profit ($ Mln) |
153.05 | -1,098.00 | 69.79 | -21.69 | -259.27 |
Net Margin (%) |
84.23 | -10.12 | 28.74 | -2.34 | -80.67 |
RoE (%) |
91.29 | -- | 5.60 | -2.00 | -29.99 |
Price to Earnings |
6.06 | -- | 17.42 | -- | -- |
Price-To-Book |
3.64 | 18.78 | 1.14 | 0.44 | 0.97 |
Cashflow ($ Mln)
| Arbutus Biopharma Corp (ABUS) | Bausch Health Companies (BHC) | Cronos Group Inc. Common Share (CRON) | Sundial Growers - ADR | Canopy Growth Corp (CGC) | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
-39.64 | 1,400.00 | 26.32 | 70.92 | -165.75 |
|
Cash Flow from Investing Activities
|
15.58 | -595.00 | -77.90 | 17.45 | -47.79 |
|
Cash from Financing Activities
|
5.72 | -742.00 | -20.25 | -54.49 | 148.66 |
|
Net Cash Inflow / Outflow
|
-- | -- | -- | -- | -- |
Ratios
Profitability Ratios
| Arbutus Biopharma Corp (ABUS) | Bausch Health Companies (BHC) | Cronos Group Inc. Common Share (CRON) | Sundial Growers - ADR | Canopy Growth Corp (CGC) | |
|---|---|---|---|---|---|
|
ROCE (%)
|
-36.37 | 0.76 | -0.89 | -1.23 | -59.69 |
|
ROE (%)
|
91.29 | -17.14 | 5.60 | -2.00 | -29.99 |
|
ROA (%)
|
46.65 | -3.57 | 5.70 | -1.58 | -22.80 |
|
EBIT Margin (%)
|
84.27 | 8.06 | 10.39 | -2.03 | -71.05 |
|
Net Margin (%)
|
84.23 | -10.12 | 28.74 | -2.34 | -80.67 |
|
Cash Profit Margin (%)
|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Growth Ratios
| Arbutus Biopharma Corp (ABUS) | Bausch Health Companies (BHC) | Cronos Group Inc. Common Share (CRON) | Sundial Growers - ADR | Canopy Growth Corp (CGC) | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
1,078.78 | 10.09 | 86.39 | -1.68 | 16.90 |
|
EBIT Growth (%)
|
367.23 | -56.81 | 162.49 | 80.39 | 49.49 |
|
Net Profit Growth (%)
|
382.12 | -1,220.41 | 277.46 | 77.94 | 49.41 |
|
EPS Growth (%)
|
374.07 | -1,242.86 | 281.14 | 77.34 | 85.64 |
|
Book Value Growth (%)
|
203.81 | -128.74 | -1.26 | 0.26 | -37.19 |
Valuation Ratios
| Arbutus Biopharma Corp (ABUS) | Bausch Health Companies (BHC) | Cronos Group Inc. Common Share (CRON) | Sundial Growers - ADR | Canopy Growth Corp (CGC) | |
|---|---|---|---|---|---|
|
Price / Earnings
|
-27.51 | 16.40 | -105.42 | -27.71 | -0.16 |
|
Price / Book Value
|
12.04 | -4.66 | 0.93 | 0.40 | 0.20 |
|
Dividend Yield (%)
|
-- | -- | -- | -- | -- |
|
EV/EBITDA
|
-25.25 | 7.07 | -54.50 | 6.96 | -0.66 |
|
Market Cap ($ Cr)
|
-- | -- | -- | -- | -- |
Solvency Ratios
| Arbutus Biopharma Corp (ABUS) | Bausch Health Companies (BHC) | Cronos Group Inc. Common Share (CRON) | Sundial Growers - ADR | Canopy Growth Corp (CGC) | |
|---|---|---|---|---|---|
|
Debt to Equity
|
0.00 | -11.22 | 0.00 | 0.00 | 0.31 |
|
Short term debt to equity ratio
|
0.00 | -0.50 | 0.00 | 0.03 | 0.06 |
|
Current Ratio
|
81.42 | 1.44 | 16.18 | 4.76 | 3.04 |
|
Quick Ratio
|
81.42 | 1.08 | 15.25 | 3.11 | 2.39 |
|
Interest Coverage
|
2,014.87 | 0.54 | -- | -3.13 | -4.92 |
Operating Efficiency Ratios
| Arbutus Biopharma Corp (ABUS) | Bausch Health Companies (BHC) | Cronos Group Inc. Common Share (CRON) | Sundial Growers - ADR | Canopy Growth Corp (CGC) | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
98.91 | 20.85 | 21.45 | 3.55 | 13.25 |
|
Asset Turnover
|
0.55 | 0.35 | 0.20 | 0.68 | 0.28 |
|
Receivable days
|
53.89 | 79.82 | 106.48 | 11.30 | 71.03 |
|
Inventory Days
|
-- | 195.23 | 166.85 | 68.84 | 167.38 |
|
Payable days
|
1,755.31 | 76.06 | 59.75 | 14.63 | 52.79 |
|
Cash Conversion Cycle
|
-- | 198.99 | 213.59 | 65.51 | 185.62 |